Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive
批准号:
7231215
负责人:
Robert J Kaner
金额:
$29.63万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2011-11-30
关键词:
AdvertisementsAgeAlveolarAlveolar MacrophagesAlveolar PatternAlveolusAnimal ModelAnimalsAreaBiologicalBiological AssayBloodCD4 Lymphocyte CountCationsChestChronicChronic DiseaseChronic Obstructive Airway DiseaseCigarette smoke-induced emphysemaClinicalCodeComplement component C1sConditioned Culture MediaControl GroupsDataDevelopmentDiseaseEffectivenessElastasesEndopeptidasesEnzyme-Linked Immunosorbent AssayEpithelialEvaluationGelatinase BGene ChipsGene ExpressionGene Expression ProfileGenesGenomeHIVHIV-1Highly Active Antiretroviral TherapyIn VitroIncidenceIndividualInfectionInjuryInterferonsInterstitial CollagenaseKnowledgeLinkLiquid substanceLungMatrix MetalloproteinasesMeasuresMediatingMediator of activation proteinMessenger RNAMethodsMiningModelingMolecularNumbersOpportunistic InfectionsPancreatic ElastasePathogenesisPathway interactionsPatientsPatternPeptide HydrolasesPharmaceutical PreparationsPhenotypePlasmaPlayPolymerase Chain ReactionPopulationPopulation StudyProtein C InhibitorProtein OverexpressionProteinsPulmonary EmphysemaRNARecording of previous eventsRecruitment ActivityResearch PersonnelResolutionRespiratory physiologyRoleScreening procedureSeriesSignal TransductionSmokeSmokerSmokingSmoking HistoryStandards of Weights and MeasuresStructure of parenchyma of lungTestingTranscription CoactivatorTranscriptional ActivationTumor Necrosis Factor-alphaTumor Necrosis FactorsUp-RegulationVirusWorkX-Ray Computed Tomographyantiretroviral therapybasecell typecigarette smokingcigarette smokingclinical phenotypecohortdisease phenotypehuman TNF proteinimprovedin vivomacrophagemetropolitannon-smokerpreventprogramstherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
With the advent of highly active antiretroviral therapy (HAART), the survival of individuals infected with
HIV-1 has dramatically improved. However, recent recognition of the markedly accelerated development
of emphysema in this population at an early age and with a minimal smoking history provides an
opportunity to study the molecular basis for this problem. In this context, the emphysema of HIV-1/AIDS
joins a1-antitrypsin deficiency as a clinical model of an accelerated form of lung destruction, and thus
HIV-1+ individuals that smoke can serve as a model to understand the pathogenesis of
emphysema. Based on the knowledge that the alveolar macrophage (AM) is the primary cell type of the
lung that is chronically infected by HIV-1, and that the AM plays a central role in releasing mediators
that mediate the lung destruction in smoking-ind.uced emphysema, we hypothesize that HIV-1 and
cigarette smoke synergize to activate AM to express a transcriptome that is highly dangerous to
the lung parenchyma. Its evaluation will help to identify the activation pathways that are most critical in
the development of emphysema and represent pharmacologic targets. Based on this background, we
propose to assess 3 specific aims. Aim 1. To test the hypothesis that HIV-1 infection and cigarette
smoking act in concert to create a pattern of AM gene expression indicative of up-regulated expression
of genes relevant to the pathogenesis of emphysema and that these changes are in excess of, or in
addition to, that induced by smoking or HIV-1 alone. Aim 2. Based on the knowledge that HIV-1
infection is associated with elevated systemic and lung levels of tumor necrosis factor-a (TNF-a) and
interferon-Y (IFN-v), and that expression of TNF-a or IFN-v in the lungs of experimental animals is
associated with the development of emphysema, we will examine the hypothesis that the exaggerated
program of emphysema-related mediators expressed by AM of HIV-1+ smokers is linked to the
overexpression of TNF-a and/or IFN-y in the lung. Aim 3. To examine the hypothesis that while HAART
therapy effectively suppresses replication of HIV-1 in the AM, it does not entirely suppress the pattern of
gene expression of the AM relevant to the pathogenesis of emphysema, and that the persistence of the
subset of up-regulated genes in the AM is linked to TNF-a or INF-v in the milieu of the alveolus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--Clinical
-
批准号:7394166
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2007
-
负责人:Robert J Kaner
-
依托单位:
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
批准号:7060059
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2005
-
负责人:Robert J Kaner
-
依托单位:
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
批准号:7227032
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2005
-
负责人:Robert J Kaner
-
依托单位:
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
批准号:6915418
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2005
-
负责人:Robert J Kaner
-
依托单位:
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
批准号:7615513
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2005
-
负责人:Robert J Kaner
-
依托单位:
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
批准号:7413971
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2005
-
负责人:Robert J Kaner
-
依托单位:
Vascular endothelial growth factor induced lung edema
-
批准号:6638522
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:Robert J Kaner
-
依托单位:
Vascular endothelial growth factor induced lung edema
-
批准号:6537540
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:Robert J Kaner
-
依托单位:
Vascular endothelial growth factor induced lung edema
-
批准号:6767749
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:Robert J Kaner
-
依托单位:
Vascular endothelial growth factor induced lung edema
-
批准号:6395211
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:Robert J Kaner
-
依托单位:
Alveolar Macrophage Host Defenses
-
批准号:6653083
-
项目类别:
-
资助金额:$33.9万
-
财政年份:1997
-
负责人:Robert J Kaner
-
依托单位:
ALVEOLAR MACROPHAGE HOST DEFENSES
-
批准号:6184319
-
项目类别:
-
资助金额:$27.45万
-
财政年份:1997
-
负责人:Robert J Kaner
-
依托单位:
Alveolar Macrophage Host Defenses
-
批准号:6788749
-
项目类别:
-
资助金额:$33.9万
-
财政年份:1997
-
负责人:Robert J Kaner
-
依托单位:
ALVEOLAR MACROPHAGE HOST DEFENSES
-
批准号:6389846
-
项目类别:
-
资助金额:$27.45万
-
财政年份:1997
-
负责人:Robert J Kaner
-
依托单位:
Alveolar Macrophage Host Defenses
-
批准号:6946919
-
项目类别:
-
资助金额:$33.9万
-
财政年份:1997
-
负责人:Robert J Kaner
-
依托单位:
Alveolar Macrophage Host Defenses
-
批准号:6543638
-
项目类别:
-
资助金额:$33.9万
-
财政年份:1997
-
负责人:Robert J Kaner
-
依托单位:
CYTOMEGALOVIRUS ACTIVATION OF VASCULAR CELL SIGNALING
-
批准号:2211086
-
项目类别:
-
资助金额:$0.95万
-
财政年份:1994
-
负责人:Robert J Kaner
-
依托单位:
CYTOMEGALOVIRUS ACTIVATION OF VASCULAR CELL SIGNALING
-
批准号:2872870
-
项目类别:
-
资助金额:$8.75万
-
财政年份:1994
-
负责人:Robert J Kaner
-
依托单位:
CYTOMEGALOVIRUS ACTIVATION OF VASCULAR CELL SIGNALING
-
批准号:2332425
-
项目类别:
-
资助金额:$7.48万
-
财政年份:1994
-
负责人:Robert J Kaner
-
依托单位:
CYTOMEGALOVIRUS ACTIVATION OF VASCULAR CELL SIGNALING
-
批准号:2211085
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1994
-
负责人:Robert J Kaner
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: